Pulmatrix Inc
(NASDAQ : PULM)

( )
PULM PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
-1.05%87.301.3%$1275.26m
AMGNAmgen Inc.
-0.25%198.891.2%$667.61m
GILDGilead Sciences, Inc.
-1.28%67.640.9%$577.79m
BIIBBiogen Inc.
-1.63%332.031.3%$485.41m
LOXOLoxo Oncology Inc
-0.18%233.2612.7%$449.60m
ILMNIllumina, Inc.
0.05%305.633.5%$350.96m
VRTXVertex Pharmaceuticals Incorporated
-0.28%186.151.9%$318.23m
REGNRegeneron Pharmaceuticals, Inc.
-0.12%404.542.6%$308.69m
ALXNAlexion Pharmaceuticals, Inc.
-0.03%111.702.0%$229.47m
TSROTESARO, Inc.
0.03%74.8814.4%$201.67m
AAgilent Technologies, Inc.
-0.82%70.021.5%$164.25m
EXASExact Sciences Corporation
-2.75%74.9725.3%$151.07m
INCYIncyte Corporation
-2.79%76.562.5%$146.84m
SRPTSarepta Therapeutics, Inc.
0.45%119.2615.4%$142.24m
LGNDLigand Pharmaceuticals Incorporated
-16.48%110.0523.1%$105.44m

Company Profile

Pulmatrix, Inc. is a clinical stage biotechnology company, which engages in the discovery and development of novel inhaled therapeutic products. The company focuses on the prevention and treatment of respiratory diseases and infections. It offers products based on its proprietary dry powder delivery technology, iSPERSE, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. The company was founded by David Edwards, Mark Gabrielson, Alexander Klibanov, and Robert Langer on June 15, 2015 and is headquartered in Lexington, MA.